AVITA Medical, Inc. (RCEL) Profit After Tax (2018 - 2026)

AVITA Medical (RCEL) has reported Profit After Tax for 9 consecutive years, with -$7.7 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Profit After Tax rose 22.75% year-over-year to -$7.7 million; the trailing twelve-month figure through Jun 2026 stood at -$42.4 million (up 17.8% YoY), and the FY2025 full-year result was -$48.6 million, up 21.44% from the prior year.
• Profit After Tax advanced to -$7.7 million in Q2 2026 per RCEL's latest filing, from -$11.6 million in the prior quarter.
• Across five years, Profit After Tax topped out at -$5.6 million in Q3 2022 and bottomed at -$18.7 million in Q1 2024.
• Historically, Profit After Tax has averaged -$11.1 million across 5 years, with a median of -$10.2 million in 2023.
• The sharpest annual moves came in 2022 and 2024: Profit After Tax surged 66.46% in 2022, then tumbled 102.36% in 2024.
• Over 5 years, Profit After Tax stood at -$9.8 million in 2022, then grew by 27.73% to -$7.1 million in 2023, then sank by 64.03% to -$11.6 million in 2024, then decreased by 0.28% to -$11.6 million in 2025, then surged by 34.06% to -$7.7 million in 2026.
• According to Business Quant data, Profit After Tax over the past three periods registered -$7.7 million, -$11.6 million, and -$13.2 million for Q2 2026, Q4 2025, and Q3 2025 respectively.